Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Kinase, CMGC GSK | 0.0527 | 1 | 1 |
Echinococcus granulosus | cyclin dependent kinase | 0.0243 | 0.2657 | 0.0427 |
Loa Loa (eye worm) | hypothetical protein | 0.023 | 0.233 | 0.2181 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.023 | 0.233 | 0.2181 |
Trypanosoma cruzi | cdc2-related kinase 1 | 0.0243 | 0.2657 | 0.0427 |
Echinococcus multilocularis | protein kinase shaggy | 0.0527 | 1 | 1 |
Echinococcus granulosus | cyclin dependent kinase 1 | 0.0243 | 0.2657 | 0.0427 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0527 | 1 | 1 |
Brugia malayi | cell division control protein 2 homolog | 0.0243 | 0.2657 | 0.2515 |
Plasmodium falciparum | glycogen synthase kinase 3 | 0.0527 | 1 | 1 |
Echinococcus granulosus | 5'partial|cyclin dependent kinase 1 | 0.0243 | 0.2657 | 0.0427 |
Entamoeba histolytica | protein kinase, putative | 0.0527 | 1 | 1 |
Echinococcus multilocularis | glycogen synthase kinase 3 beta | 0.0527 | 1 | 1 |
Echinococcus multilocularis | G2:mitotic specific cyclin B3 | 0.0368 | 0.5887 | 0.4638 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0243 | 0.2657 | 0.2657 |
Trichomonas vaginalis | cyclins, putative | 0.023 | 0.233 | 0.233 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0243 | 0.2657 | 0.2657 |
Schistosoma mansoni | cyclin-dependent kinase 5 activator | 0.0307 | 0.4321 | 0.2596 |
Trichomonas vaginalis | cyclin B, putative | 0.023 | 0.233 | 0.233 |
Trichomonas vaginalis | cyclins, putative | 0.023 | 0.233 | 0.233 |
Trypanosoma cruzi | glycogen synthase kinase 3, putative | 0.0527 | 1 | 1 |
Loa Loa (eye worm) | cyclin domain-containing protein | 0.0368 | 0.5887 | 0.5807 |
Toxoplasma gondii | cell-cycle-associated protein kinase GSK, putative | 0.0527 | 1 | 1 |
Trichomonas vaginalis | cyclins, putative | 0.023 | 0.233 | 0.233 |
Echinococcus multilocularis | cyclin dependent kinase 5 | 0.0243 | 0.2657 | 0.0427 |
Onchocerca volvulus | 0.0527 | 1 | 1 | |
Giardia lamblia | Kinase, CMGC GSK | 0.0527 | 1 | 1 |
Plasmodium vivax | glycogen synthase kinase 3, putative | 0.0527 | 1 | 1 |
Echinococcus granulosus | cyclin dependent kinase 5 activator 1 | 0.0307 | 0.4321 | 0.2596 |
Loa Loa (eye worm) | hypothetical protein | 0.0235 | 0.2462 | 0.2316 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0368 | 0.5887 | 0.5807 |
Echinococcus granulosus | glycogen synthase kinase 3 beta | 0.0527 | 1 | 1 |
Trypanosoma brucei | protein kinase, putative | 0.0527 | 1 | 1 |
Echinococcus multilocularis | cyclin dependent kinase 1 | 0.0243 | 0.2657 | 0.0427 |
Leishmania major | cell division protein kinase 2,cdc2-related kinase | 0.0243 | 0.2657 | 0.0427 |
Loa Loa (eye worm) | hypothetical protein | 0.0307 | 0.4321 | 0.4211 |
Loa Loa (eye worm) | CMGC/CDK/CDK5 protein kinase | 0.0243 | 0.2657 | 0.2515 |
Trypanosoma cruzi | cdc2-related kinase 3 | 0.0243 | 0.2657 | 0.0427 |
Trichomonas vaginalis | cyclin B, putative | 0.023 | 0.233 | 0.233 |
Brugia malayi | Protein kinase domain containing protein | 0.0243 | 0.2657 | 0.2515 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0527 | 1 | 1 |
Giardia lamblia | Kinase, CMGC CDK | 0.0243 | 0.2657 | 0.0427 |
Echinococcus multilocularis | cyclin dependent kinase | 0.0243 | 0.2657 | 0.0427 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0527 | 1 | 1 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0527 | 1 | 1 |
Entamoeba histolytica | cell division protein kinase 2, putative | 0.0243 | 0.2657 | 0.0427 |
Entamoeba histolytica | cell division protein kinase 2, putative | 0.0243 | 0.2657 | 0.0427 |
Trypanosoma cruzi | cdc2-related kinase 3 | 0.0243 | 0.2657 | 0.0427 |
Echinococcus granulosus | G2:mitotic specific cyclin B3 | 0.0368 | 0.5887 | 0.4638 |
Leishmania major | glycogen synthase kinase, putative;with=GeneDB:LinJ18_V3.0270 | 0.0527 | 1 | 1 |
Trichomonas vaginalis | cyclin B, putative | 0.023 | 0.233 | 0.233 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0243 | 0.2657 | 0.0427 |
Echinococcus multilocularis | cyclin dependent kinase 5 activator 1 | 0.0307 | 0.4321 | 0.2596 |
Trypanosoma brucei | cdc2-related kinase 1 | 0.0243 | 0.2657 | 0.0427 |
Schistosoma mansoni | cyclin B3 | 0.0368 | 0.5887 | 0.4638 |
Trichomonas vaginalis | cyclin B, putative | 0.023 | 0.233 | 0.233 |
Trypanosoma cruzi | cdc2-related kinase 1 | 0.0243 | 0.2657 | 0.0427 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.023 | 0.233 | 0.2181 |
Trypanosoma brucei | cdc2-related kinase 3 | 0.0243 | 0.2657 | 0.0427 |
Trichomonas vaginalis | cyclins, putative | 0.023 | 0.233 | 0.233 |
Echinococcus granulosus | cyclin dependent kinase 5 | 0.0243 | 0.2657 | 0.0427 |
Echinococcus multilocularis | cyclin dependent kinase 1 | 0.0243 | 0.2657 | 0.0427 |
Schistosoma mansoni | glycogen synthase kinase 3-related (gsk3) (cmgc group III) | 0.0527 | 1 | 1 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.0243 | 0.2657 | 0.2515 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0527 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.023 | 0.233 | 0.2181 |
Leishmania major | cell division related protein kinase 2,cdc2-related kinase | 0.0243 | 0.2657 | 0.0427 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.0243 | 0.2657 | 0.2515 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0527 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0243 | 0.2657 | 0.0427 |
Echinococcus granulosus | protein kinase shaggy | 0.0527 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0243 | 0.2657 | 0.2657 |
Trichomonas vaginalis | cyclin A, putative | 0.023 | 0.233 | 0.233 |
Giardia lamblia | Kinase, CMGC CDK | 0.0243 | 0.2657 | 0.0427 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 82 % | Antiviral activity against TMV at 500 mg/L | ChEMBL. | 17055269 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.